-transparent.png){kind=logo}
The effect of propranolol treatment (60 mg per day, three days) on glucose disposal rate (K-value) was investigated in nine patients with hyperthyroidism. K-value was improved in 4 cases and aggravated in 5 cases. The fasting levels of plasma free fatty acids (FFA) before the administration of propranolol in the improved cases were significantly higher than those in the aggravated cases. The propranolol treatment markedly reduced FFA levels only in the improved cases. These results suggest that the impaired glucose tolerance frequently seen in hyperthyroidism patients could be partly attributed to the increased level of plasma FFA.
Related Publications
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
November 1977,
Postgraduate medical journal,
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
February 2018,
BMC research notes,
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
January 1991,
Endokrynologia Polska,
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
July 1979,
Polskie Archiwum Medycyny Wewnetrznej,
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
February 2000,
Vnitrni lekarstvi,
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
May 1967,
Wiener klinische Wochenschrift,
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
January 1988,
Medicina,
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
September 1974,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
July 1993,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R Kikkawa, and
S Ohmori, and
M Haneda, and
Y Shigeta
October 1980,
La Nouvelle presse medicale,
